Page 5,984«..1020..5,9835,9845,9855,986..5,9906,000..»

Harris Teeter Pharmacy…You're Invited! – Video

Posted: Published on December 7th, 2012

Harris Teeter Pharmacy...You're Invited! Check out more information about Harris Teeter's Pharmacy! http://www.harristeeter.comFrom:MyHarrisTeeterViews:0 0ratingsTime:00:35More inFilm Animation Read this article: Harris Teeter Pharmacy...You're Invited! - Video … Continue reading

Posted in Pharmacy | Comments Off on Harris Teeter Pharmacy…You're Invited! – Video

Walgreens Completes Transaction to Gain Ownership Stake in Cystic Fibrosis Specialty Pharmacy

Posted: Published on December 7th, 2012

DEERFIELD, Ill. & BETHESDA, Md.--(BUSINESS WIRE)-- Walgreens (WAG) (WAG) and the Cystic Fibrosis Foundation today announced they have completed a transaction giving Walgreens a significant ownership stake in Cystic Fibrosis Foundation Pharmacy LLC, the parent company of Cystic Fibrosis Services Inc. The transaction gives Walgreens and the CF Foundation joint ownership of two businesses: CF Services, a specialty pharmacy for CF patients and their families; and Pharma Dynamics Inc., a provider of new product launch support and call center services for drug manufacturers. CF Services will continue to operate under its current name and remain based in the same location in Bethesda, Md. Pharma Dynamics Inc. was previously CF Services Corporate Accounts Division. Terms of the agreement were not disclosed. About Walgreens As the nation's largest drugstore chain with fiscal 2012 sales of $72 billion, Walgreens (www.walgreens.com) vision is to become Americas first choice for health and daily living. Each day, Walgreens provides more than 6 million customers the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice in communities across America. Walgreens scope of pharmacy services includes retail, specialty, infusion, medical facility and mail service, along with respiratory services. … Continue reading

Posted in Pharmacy | Comments Off on Walgreens Completes Transaction to Gain Ownership Stake in Cystic Fibrosis Specialty Pharmacy

Meningitis victims can likely inspect pharmacy

Posted: Published on December 7th, 2012

BOSTON (AP) -- Victims of a meningitis outbreak tied to a Massachusetts compounding pharmacy will likely be allowed to do an exhaustive inspection of the facility, a federal judge said Thursday. U.S. Magistrate Judge Jennifer Boal said she is inclined to allow the inspection by experts and lawyers for more than a dozen victims who filed lawsuits in Massachusetts against the New England Compounding Center. The plaintiffs allege that they contracted fungal meningitis from contaminated steroid injections made by NECC. Health officials say 36 people have died and more than 500 others have been sickened nationwide by the injections. Judi Abbott Curry, an NECC attorney, said the company agrees that the plaintiffs' lawyers have the right to inspect the facility, but she argued that the inspection should be conducted after a federal judicial panel rules on whether the lawsuits in Massachusetts and hundreds more around the country should be consolidated before a single court. A judicial panel is scheduled to hold a hearing on that issue in January. But Boston attorney Kimberly Dougherty, legal liaison for the lawsuits filed in Massachusetts, said the victims should be allowed to do the inspection as soon as possible. Dougherty said they want to … Continue reading

Posted in Pharmacy | Comments Off on Meningitis victims can likely inspect pharmacy

WISE Surgical Solutions LLC Announces Project Hope: Helping People with Debilitating Conditions Including Arthritis …

Posted: Published on December 6th, 2012

With millions of people in aggregate suffering from debilitating disease, reduced mobility, or relentless pain associated with various conditions, stem cell medicine is available now through WISE Surgical Solutions LLC by direct flight from some major cities to our Joint Commission International Accredited Johns Hopkins affiliated Punta Pacifica Hospital in Panama. New York (PRWEB) December 06, 2012 Cathy Nenninger, Chief Executive Officer of WISE Surgical Solutions LLC, shared why this offering is important. When I ran wound centers up and down the east coast, I used to get calls from patients and family members desperate for treatments to help alleviate severe symptoms of ailments such as these. It was heartbreaking that we were not able to provide any type of help or hope to these patients. Granted, while the response and success of stem cell treatment in patients varies greatly and by disease, patients who are in extreme discomfort or experiencing reduced function or quality of life deserve to know that they have options available to them. A significant element of PROJECT HOPE, continues Ms. Nenninger, is the opportunity for community funding of the treatment. Often, families and communities want to help someone by making donations that will collectively fund … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on WISE Surgical Solutions LLC Announces Project Hope: Helping People with Debilitating Conditions Including Arthritis …

Stem Cell Therapy for Animals Q

Posted: Published on December 6th, 2012

Stem Cell Therapy for Animals Q A at Animal Clinic of - Captured Live on Ustream at http://www.ustream.tvFrom:HawaiiWellnessDirViews:0 0ratingsTime:39:36More inPeople Blogs Read the original here: Stem Cell Therapy for Animals Q … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Stem Cell Therapy for Animals Q

PTC Therapeutics Announces European Medicines Agency Validation of Marketing Authorization Application for Ataluren in …

Posted: Published on December 6th, 2012

SOUTH PLAINFIELD, N.J., Dec. 6, 2012 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced that the European Medicines Agency (EMA) has validated a Marketing Authorization Application (MAA) seeking conditional approval for ataluren, an investigational new drug for the treatment of patients with nonsense mutation Duchenne muscular dystrophy (nmDMD). Validation of the MAA confirms that the submission is complete and begins the EMA's Committee for Human Medicinal Products' (CHMP) review process. Ataluren is the only treatment currently in clinical development targeting the cause of disease in patients with a nonsense mutation. (Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO) "Ataluren is a promising potential therapy for nonsense mutation Duchenne muscular dystrophy," stated Dr. Thomas Voit, Medical and Scientific Director, Institut de Myologie. "PTC has developed a standard for DMD clinical trials and now the DMD community can share in the achievement of the first MAA ever filed for DMD. We appreciate PTC's commitment to the clinical development of ataluren for this severe disorder for which only palliative treatment options currently exist." The Marketing Authorization Application's submission was accepted by EMA for review on the basis of a 48-week, 174-patient Phase 2b study showing that nmDMD patients treated with ataluren (10, 10, 20 mg/kg given daily) walked on … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on PTC Therapeutics Announces European Medicines Agency Validation of Marketing Authorization Application for Ataluren in …

T Malterre, CN: Food’s Role in Treatment – Video

Posted: Published on December 6th, 2012

T Malterre, CN: Food's Role in Treatment What Role Does Food Play in Autism Treatment? Presented by Tom Maltere, MS, CN at the Fall 2012 Autism Research Institute ConferenceFrom:arifultonViews:2 0ratingsTime:01:00:54More inEducation Read the original: T Malterre, CN: Food's Role in Treatment - Video … Continue reading

Comments Off on T Malterre, CN: Food’s Role in Treatment – Video

L Mumper, MD: Medical Problems

Posted: Published on December 6th, 2012

L Mumper, MD: Medical Problems ASD Presented by Elizabeth Mumper, MD at the Fall 2012 Autism Research Institute Conference Dr. Mumper provides an evidence-based overview of medical problems often found in children with autism, so that parents and clinicians can collaborate on assessments and treatment strategies.From:arifultonViews:0 0ratingsTime:01:04:26More inEducation Go here to see the original: L Mumper, MD: Medical Problems … Continue reading

Comments Off on L Mumper, MD: Medical Problems

Stroke study into antidepressants

Posted: Published on December 6th, 2012

Antidepressants could help recovery after a stroke - even in patients who are not depressed, research has suggested. The drugs could reduce dependence, physical disability, depression and anxiety in the first year after a stroke, according to the study published in the Cochrane Library. Antidepressants could promote the growth of new nerve cells in the brain or protect other cells damaged by stroke, said the authors. And by preventing depression they may encourage more patients to be physically active, they suggested. Researchers at the University of Edinburgh examined 52 studies concerning selective serotonin reuptake inhibitors. Professor Gillian Mead, professor of stroke and elderly care medicine at the university, said: "Antidepressants have been successfully used for many years to relieve depression. However, it now appears that they also have effects on the brain that may help patients make a better recovery from the physical effects of stroke. "The results of this meta-analysis are extremely promising. We do not yet fully understand how antidepressants could boost recovery after stroke, but it may be because they promote the growth of new nerve cells in the brain, or protect cells damaged by stroke. Also, by preventing depression, the drugs may help patients to be … Continue reading

Comments Off on Stroke study into antidepressants

Good News in Stroke Prevention: New Unique Treatment Now Approved

Posted: Published on December 6th, 2012

New option available for Canadians with irregular heart rhythm in need of crucial therapy OTTAWA, Dec. 6, 2012 /CNW/ - The Stroke Survivors Association of Ottawa welcomes the recent approval by Health Canada of Eliquis (apixaban), a new anti-blood clotting therapy to prevent strokes in people with atrial fibrillation (AF), a condition involving an irregular heart rhythm which greatly increases the risk of disabling and fatal strokes. "Strokes caused by AF are preventable, yet still, one in five strokes are in people with AF. Even with the recent introduction of new treatments, there are patients who are not getting the effective therapy they need and they remain at risk," said Janet McTaggart, Executive Director of the Stroke Survivors Association of Ottawa. "We are very encouraged by the Health Canada approval of Eliquis, providing another prevention option. Ensuring access to these preventative therapies in all patients with atrial fibrillation would result in fewer fatal and debilitating strokes." One third of all strokes in people over age 60 are in people with AF and the strokes they have tend to be more serious, causing greater disability and twice as high a risk of death. Until the recent introduction of newer anticoagulation drugs, … Continue reading

Comments Off on Good News in Stroke Prevention: New Unique Treatment Now Approved

Page 5,984«..1020..5,9835,9845,9855,986..5,9906,000..»